Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells

被引:13
作者
Hurd, C [1 ]
Rozengurt, E [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Div Digest Dis, Unit Surg Transduct & Gastrointestinal Canc, Los Angeles, CA 90095 USA
关键词
protein kinase D; EGF; c-Jun; JNK; Ser; 63; lung cancer; pancreatic cancer; A549; cells; panel cells; phosphorylation;
D O I
10.1016/S0006-291X(03)00268-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase D (PKD) has been established as a negative modulator of the c-Jun N-terminal kinase (JNK) signaling pathway. We previously demonstrated that induced expression of constitutively active PKD (PKD-S744/749E) that mimics phosphorylation by PKC is sufficient to attenuate epidermal growth factor (EGF) stimulated c-Jun Ser 63 phosphorylation, a natural substrate of JNK, in HEK 293 cells. Because the JNK pathway has been implicated in sustaining both lung and pancreatic cancerous phenotypes, we have utilized stable inducible expression of PKD-S744/748E in clones of A549 non-small cell lung cancer (NSCLC) and Panc1, pancreatic cancer cells to determine its effects on JNK signaling in the context of the cancerous phenotype. In contrast to HEK 293 cells, induced expression of PKD-S744/748E in either A549 NSCLC or Panel cells failed to attenuate EGF dependent phosphorylation of c-Jun, indicating that EGF stimulated JNK phosphorylation of c-Jun is uncoupled from PKD suppression in these cancer cells. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:800 / 804
页数:5
相关论文
共 33 条
[1]   Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor [J].
Bagowski, CP ;
Stein-Gerlach, M ;
Choidas, A ;
Ullrich, A .
EMBO JOURNAL, 1999, 18 (20) :5567-5576
[2]  
Bost F, 1999, MOL CELL BIOL, V19, P1938
[3]   The JUN kinase stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells [J].
Bost, F ;
McKay, R ;
Dean, N ;
Mercola, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :33422-33429
[4]   Protein kinase C (PKC) η-mediated PKCμ activation modulates ERK and JNK signal pathways [J].
Brändlin, I ;
Hübner, S ;
Eiseler, T ;
Martinez-Moya, M ;
Horschinek, A ;
Hausser, A ;
Link, G ;
Rupp, S ;
Storz, P ;
Pfizenmaier, K ;
Johannes, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6490-6496
[5]  
Chen Jie, 1994, Zentralblatt fuer Pathologie, V140, P265
[6]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[7]   Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras:: implications for cell proliferation and cell migration [J].
Giehl, K ;
Skripczynski, B ;
Mansard, A ;
Menke, A ;
Gierschik, P .
ONCOGENE, 2000, 19 (25) :2930-2942
[8]  
Guha S, 2002, CANCER RES, V62, P1632
[9]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[10]   Protein kinase C μ selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway [J].
Hausser, A ;
Storz, P ;
Hübner, S ;
Braendlin, I ;
Martinez-Moya, M ;
Link, G ;
Johannes, FJ .
FEBS LETTERS, 2001, 492 (1-2) :39-+